News >

Expert Highlights Multitargeted Treatments in Hematologic Malignancies

Danielle Ternyila
Published: Wednesday, Mar 18, 2020

David S. Hong, MD, deputy director of the Department of investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

David S. Hong, MD

Multitargeted therapies are rapidly emerging as an exciting new option for the treatment of patients with hematologic malignancies, said David S. Hong, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication